GUTS
FRACTYL HEALTH, INC.
+0.03 (+5.31%)0.59USD399K成交股數94.4M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 14K-61% | 43K-40% | 33K | 7K | 36K | 72K |
| 營業成本 | – | – | – | – | – | – | 7K | 24K | 19K | 2K | 25K | 47K |
| 毛利 | – | – | – | – | – | – | 7K-36% | 19K-24% | 14K | 5K | 11K | 25K |
| 毛利率 | – | – | – | – | – | – | 50.0% | 44.2% | 42.4% | 71.4% | 30.6% | 34.7% |
| 研發費用 | 13.8M | 15.6M | 16.5M | 17.5M | 21.2M | 19.4M | 19.0M | 16.8M | 14.4M | 10.2M | 9.4M | 9.1M |
| 銷售管理費用 | 5.3M | 5.2M | 6.8M | 5.2M | 4.9M | 5.3M | 4.8M | 6.2M | 7.1M | 2.8M | 4.5M | 2.8M |
| 營業利益 | −19.1M-27% | −20.8M-16% | −23.3M-2% | −22.7M-1% | −26.1M+21% | −24.8M+91% | −23.8M+72% | −23.0M+94% | −21.5M | −13.0M | −13.9M | −11.9M |
| 營業利益率 | – | – | – | – | – | – | -169,957.1% | -53,453.5% | -65,278.8% | -185,442.9% | -38,536.1% | -16,493.1% |
| 稅後淨利 | −25.5M-8% | 9.2M-139% | −43.7M+89% | −45.6M+165% | −27.9M+740% | −23.7M+24% | −23.2M+47% | −17.2M-43% | −3.3M | −19.2M | −15.7M | −30.2M |
| 淨利率 | – | – | – | – | – | – | -165,521.4% | -40,067.4% | -10,066.7% | -274,000.0% | -43,741.7% | -41,988.9% |
| 稀釋 EPS | -0.16-72% | 0.06-112% | -0.09-81% | -0.71+97% | -0.57+235% | -0.49-96% | -0.48-95% | -0.36-98% | -0.17 | -11.19 | -9.61 | -16.62 |
| 稀釋股數 | 159M | 158M | 75.8M | 64.7M | 49.0M | 48.9M | 48.0M | 47.9M | 29.7M | 2.1M | 2.1M | 2.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 47.1M | 63.2M | 81.5M | 77.7M | 22.3M | 42.1M | 84.7M | 102M | 121M | 33.2M | 49.1M | 32.3M |
| 應收帳款 | – | – | – | – | – | – | 0.00 | 22K | 15K | 22K | – | – |
| 存貨 | – | – | – | – | – | – | 73K | 64K | 73K | 73K | – | – |
| 總資產 | 82.0M | 99.4M | 121M | 114M | 62.0M | 83.0M | 127M | 146M | 164M | 76.2M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 83.6M | 78.0M | 112M | 117M | 80.2M | 76.7M | 76.6M | 75.7M | 79.3M | 114M | – | – |
| 股東權益 | −1.7M | 21.4M | 9.5M | −3.2M | −18.2M | 6.4M | 50.3M | 70.8M | 84.2M | −325M | −307M | −293M |
| 負債比 | 102.0% | 78.5% | 92.2% | 102.8% | 129.4% | 92.3% | 60.4% | 51.7% | 48.5% | 149.5% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.5M-10% | – | – | – | −25.1M | – | – | −11.7M | – | – | – |
| 資本支出 | – | – | – | – | – | 448K | – | – | 1.1M | – | – | – |
| 自由現金流 | – | – | – | – | – | −25.5M | – | – | −12.8M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -38,697.0% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −141M | –% | -1.86 | −90.9M |
| FY2024 | 93K | -22.5% | −68.7M | -73,864.5% | -1.62 | −67.3M |
| FY2023 | 120K | – | −77.1M | -64,242.5% | -45.29 | −43.2M |